Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,226.00p on 19-02-2026 at 19:35:09
Change -42.00p -1.85%
Buy 2,225.00p
Sell 2,224.00p
Last Trade: Sell 66,201.00 at 2,237.43p
Day's Volume: 12,562,351
Last Close: 2,226.00p
Open: 2,252.00p
ISIN: GB00BN7SWP63
Day's Range 2,216.00p - 2,264.00p
52wk Range: 1,242.50p - 2,282.00p
Market Capitalisation: £89.34b
VWAP: 2,238.18901p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 66,201 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 622 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 5,020 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 352,680 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 40,967 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 15,534 2,237.43p SI Trade
Suspected SELL Trade
16:52:09 - 19-Feb-26
Sell* 963 2,226.00p SI Trade
Suspected SELL Trade
16:49:31 - 19-Feb-26
Sell* 792 2,226.00p SI Trade
Suspected SELL Trade
16:49:31 - 19-Feb-26
Buy* 15,330 2,252.50p SI Trade
Negotiated Trade
16:48:15 - 19-Feb-26
Buy* 31,667 2,232.289p SI Trade
Negotiated Trade
16:42:05 - 19-Feb-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
19th Feb 2026 (Thu) 2,252.00 2,264.00 2,216.00 2,226.00 12,562,351
18th Feb 2026 (Wed) 2,243.00 2,282.00 2,243.00 2,268.00 13,280,520
17th Feb 2026 (Tue) 2,194.00 2,259.00 2,189.00 2,239.00 9,155,075
16th Feb 2026 (Mon) 2,172.00 2,187.00 2,153.00 2,184.00 8,105,053
13th Feb 2026 (Fri) 2,170.00 2,171.00 2,137.00 2,165.00 13,836,859
12th Feb 2026 (Thu) 2,143.00 2,149.00 2,110.00 2,141.00 4,835,448
11th Feb 2026 (Wed) 2,161.00 2,168.00 2,126.00 2,150.00 8,124,944
10th Feb 2026 (Tue) 2,163.00 2,187.00 2,132.00 2,168.00 16,786,766
9th Feb 2026 (Mon) 2,200.00 2,219.00 2,156.00 2,159.00 19,198,914
6th Feb 2026 (Fri) 2,166.00 2,198.00 2,152.00 2,198.00 8,478,262
5th Feb 2026 (Thu) 2,090.00 2,196.00 2,083.00 2,180.00 16,400,217
4th Feb 2026 (Wed) 1,935.50 2,111.00 1,920.00 2,080.00 16,788,662
3rd Feb 2026 (Tue) 1,922.50 1,945.50 1,919.00 1,945.50 6,775,935
2nd Feb 2026 (Mon) 1,882.50 1,927.50 1,875.00 1,925.00 12,846,159
30th Jan 2026 (Fri) 1,836.00 1,876.50 1,823.00 1,876.50 8,924,204
29th Jan 2026 (Thu) 1,812.00 1,859.00 1,811.00 1,852.00 9,993,355
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
26th Jan 2026 (Mon) 1,802.50 1,833.00 1,795.00 1,828.50 3,634,721
23rd Jan 2026 (Fri) 1,814.00 1,814.00 1,796.00 1,801.00 9,062,710
22nd Jan 2026 (Thu) 1,792.50 1,808.00 1,776.50 1,804.50 4,820,384
21st Jan 2026 (Wed) 1,786.50 1,798.50 1,777.00 1,787.50 6,414,843
20th Jan 2026 (Tue) 1,802.00 1,805.50 1,774.00 1,795.50 7,498,672
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
19th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
19th Feb 2026 7:00 am RNS Transaction in Own Shares
18th Feb 2026 7:00 am RNS Transaction in Own Shares
17th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
17th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
17th Feb 2026 7:00 am RNS GSK - fourth tranche of share buyback programme
17th Feb 2026 7:00 am RNS Exdensur approved by the European Commission
16th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
16th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
16th Feb 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK starts GBP450 million buyback tranche as EU approves Exdensur drug

17th Feb 2026 12:54

(Alliance News) - GSK PLC on Tuesday announced the beginning of the fourth tranche of a GBP2 billion buyback programme, worth GBP450 million. Read More

LONDON BROKER RATINGS: Peel Hunt cuts InterContinental Hotels - 'hold'

17th Feb 2026 09:50

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

13th Feb 2026 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

13th Feb 2026 07:58

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More

UK dividends calendar - next 7 days

12th Feb 2026 17:26

Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,627.04
Change-59.14

Login to your account

Forgot Password?

Not Registered